Management
MANAGEMENT STAFF
KELLEY MOREMEN, PH.D.
President & CEO
Dr. Moremen received his B.S. in Biology and Chemistry (1978) from Dickinson College and his Ph.D. in Molecular Biology (1984) from Vanderbilt University and a pursued postdoctoral training at the Massachusetts Institute of Technology. In 1991, Dr. Moremen joined the faculty of the Complex Carbohydrate Research Center at the University of Georgia where he is now Professor in the Department of Biochemistry and Molecular Biology. Dr. Moremen has chaired the Glycobiology Gordon Research Conference, served as President, member of the Board of Directors, and Secretary of the Society for Glycobiology. He presently directs efforts on an NIH funded multi-investigator 'Resource for Integrated Glycotechnology', is a senior investigator on the NIH-funded 'National Center for Biomedical Glycomics', and is a lead Principal Investigator or Senior Investigator on eight additional grants from the NIH and Department of Energy. He has served on editorial boards of Journal of Biological Chemistry, Glycobiology, and Glycoconjugate Journal, numerous NIH grant review panels, and Scientific Advisory Boards of four biotech companies. In 2014 Dr. Moremen was appointed the Distinguished Research Professorship in Biochemistry and Molecular Biology at the University of Georgia and has a total of 10 patents and over 150 peer-reviewed publications. In 2018, he launched the biotech startup, Glyco Expression Technologies, Inc., that is located in the UGA Innovation Gateway.
ALISON NAIRN, PH.D.
CSO
Dr. Nairn received her B.S. in Microbiology (1989) and her M.S. in Microbiology and Molecular Biology (1993) from the University of Central Florida. Dr. Nairn then attended the University of Georgia to pursue her doctoral degree in Biochemisty (2001) in the laboratory of Dr. Kelley Moremen. Following two years of postdoctoral training in the departments of Biochemistry and the Center for Tropical and Emerging Global Diseases at the University of Georgia, Dr. Nairn re-joined the Moremen lab at the Complex Carbohydrate Research Center to investigate Transcriptomics in murine and human stem cells, as part of the NIH-funded 'National Center for Biomedical Glycomics'. She compiled collections of glycan-related genes for both murine and human systems and directed a team of undergraduates and technicians to generate validated primer sets to evaluate transcriptome data on over 800 genes in each system. In 2008, she was promoted to Assistant Research Scientist and in 2013, she was promoted to Associate Research Scientist. During the course of funding for the Biomedical Glycomics grant, Dr. Nairn collaborated with investigators in the U.S. and abroad, carrying out transcript analysis in cells and tissues in organisms from zebrafish to humans. She created pathways for N-linked, O-linked, Glycolipid, Glycosaminoglycan, GPI anchor and nucleotide sugar biosynthesis and catabolism in order to present transcriptomic data in a meaningful manner. In 2018, she completed an NSF-funded UGA I-CORPS training program at the UGA Innovation Gateway in preparation for her role as Chief Scientific Officer of Glyco Expression Technologies.
© Copyright 2018 | All Rights Reserved | Glyco Expression Technologies, Inc.
